Hyponatremia as a complication of selective serotonin reuptake inhibitors

Journal of the American Academy of Nurse Practitioners

Volumn 20, Issue 1, 2008, Pages 47-51

  Wright, Stephanie K ^a,c   Schroeter, Stefanie ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b Unity Health Care Inc   (United States)

^c NONE   (United States)

Author keywords

Depression; Elderly; Hyponatremia; SIADH; SSRI

Indexed keywords

HYDROCHLOROTHIAZIDE; SEROTONIN UPTAKE INHIBITOR;

AGED; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DEPRESSION; DRUG COMBINATION; DRUG INTERACTION; FEMALE; HUMAN; HYPONATREMIA; RISK FACTOR;

AGED; AGED, 80 AND OVER; DEPRESSIVE DISORDER; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPONATREMIA; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 37849023515     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2007.00280.x     Document Type: Article

References (24)

1. Arinson, Z. H., Lehman, Y. A., Fidelman, Z. G. Krasnyansky, II (2002). Delayed recurrent SIADH associated with SSRIs. Annals of Pharmacology, 36, 1175 1177.
2. Bell, C. Anderson, D 1998). SSRI-induced hyponatraemia. International Journal of Geriatric Psychiatry, 13, 127 129.
3. Bourgeois, J. A 2005). Reversible hyponatremia and venlafaxine. Psychosomatics, 46, 495 496.
4. Corrington, K. A., Gatlin, C. C. Fields, K. B 2002). A case of SSRI-induced hyponatremia. Journal of the American Board of Family Practice, 15, 63 65.
5. Fabian, T. J., Amico, J. A., Kroboth, P. D., Mulsant, B. H., Corey, S. E., Begley, A. E., et al 2004). Paroxetine-induced hyponatremia in older adults: A 12 week prospective study. Archives of Internal Medicine, 164, 327 332.
6. Fochtmann, L. J. Gelenberg, A. J 2005). Guidelines watch: Practice guidelines for the treatment of patients with major depressive disorder (2nd ed American Psychiatric Association. Retrieved March 14, 2007, from http://www.psych.org/psych_pract/treatg/pg/MDD.watch.pdf/
7. Grikiniene, J., Volbekas, V. Stakisaitis, D 2004). Gender differences of sodium metabolism and hyponatremia as an adverse drug effect. Medicine (Kaunas), 40, 935 942.
8. Harman, J. S., Crystal, S., Walkup, J. Olfson, M 2003). Trends in elderly patients' office visits for the treatment of depression according to physician specialty: 1985-1999. Journal of Behavioral Health Services & Research, 30, 332 341.
9. Hwang, A. S. Magraw, R. M 1989). Syndrome of inappropriate secretion of antidiuretic hormone due to fluoxetine. American Journal of Psychiatry, 146, 399.
10. Juss, J. K., Radhamma, A. K. J. Forsyth, D. R 2005). Tolteradine-induced hyponatremia. Age and Aging, 34, 524 525.
11. Kazal, L. A., Hall, D. L., Miller, L. G. Noel, M. L 1993). Fluoxetine-induced SIADH: A geriatric occurrence? Journal of Family Practice, 36, 341 343.
12. Miehle, K., Paschke, R. Koch, C. A 2005). Citalopram therapy as a risk factor for symptomatic hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): A case report. Pharmacopsychiatry, 38, 181 182.
13. Movig, K. L. L., Leufkens, H. G. M. Lenderink, A. W 2002). Serotonergic antidepressants associated with an increased risk for hyponatremia in the elderly. European Journal of Clinical Pharmacology, 58, 143 148.
14. Rosner, M. H 2004). Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors. American Journal of the Medical Sciences, 327, 109 111.
15. Roxanas, M. G 2003). Mirtazapine-induced hyponatremia. Medical Journal of Australia, 179, 453 454.
16. Spigset, O. Hedenmalm, K 1995). Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. (1995). Drug Safety, 12, 209 225.
17. Spigset, O. Hedenmalm, K 1997). Hyponatremia in relation to treatment with antidepressants: A survey of reports in the World Health Organization database for spontaneous reporting of adverse drug reactions. Pharmacotherapy, 17, 348 352.
18. Stedman, C. A. M., Begg, E. J., Kennedy, M. A., Roberts, R. Wilkinson, T. J 2002). Cytochrome p450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatremia. Human Psychopharmacology: Clinical & Experimental, 17, 187 190.
19. Strachan, J. Shepherd, J 1998). Hyponatremia associated with the use of selective serotonin re-uptake inhibitors. Australian and New Zealand Journal of Psychiatry, 32, 295 298.
20. Tatro, D. S., ed 2007). A to Z drug facts (6th ed). Retrieved March 13, 2007, from http://gateway.ut.ovid.com/
21. U.S. Food and Drug Administration 2007). FDA approved drug products: Prozac (018936). Retrieved March 3, 2007, from http://www.accessdata.fda.gov/ scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails/
22. Vanhaesebrouck, P., Bock, F., Zecic, A., DePraeter, C., Smets, K., DeCoen, K., et al 2005). Phototherapy-mediated syndrome of inappropriate secretion of antidiuretic hormone in an intern selective serotonin reuptake inhibitor-exposed newborn infant. Pediatrics, 115, e508 e511.
23. Wakita, M., Matsuoka, H., Hamada, R., Okatsu, H., Nakajima, T. Osame, M 2005). Hyponatremia upon resumption of paroxetine therapy. Internal Medicine, 44, 240 242.
24. Wilkinson, T. J., Begg, E. J., Winter, A. C. Sainsbury, R 1999). Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Clinical Pharmacology, 47, 211 217.